Association between Rutherford Classification and CHA2DS2-VASc, CHADS2 and ASCVD Scores in Peripheral Artery Disease Patients

Abstract

Although the CHADS 2 scoring system was first used, after than the CHA 2 DS 2 -VASc scoring system which became standard, has been proven effective for assessing the prognostic risk of thromboembolism in nonvalvular Atrial Fibrillation (AF) patients [4]. Some scoring systems have been developed to evaluate and treat the risk of atherosclerotic Cardiovascular (CV) disease in adults without known cardiovascular disease. One of them is the atherosclerotic cardiovascular disease (×) Risk Estimator, which has been used frequently in recent years and is recommended by the American College of Cardiology and the American Heart Association [5].These scoring systems and cardiovascular and cerebrovascular diseases have similar risk factors and may be useful even to assess the severity of atherosclerotic diseases. There is little and improper data on the relationship between PAD and risk scores. Rutherford classification is used to identify the severity of the clinical symptoms with objective findings in PAD. In this study, our aim was to investigate the association of the Rutherford classification and CHADS 2 , CHA 2 DS 2 -VASc and ASCVD scores in PAD patients.

A Combined Treatment Effect of Cilostazol and Pentoxifylline in the Treatment of Peripheral Vascular Disease

“…The clinical symptoms of lower limb arterial disease include intermittent claudication and the absence of peripheral pulses in the lower leg and foot [3]. Intermittent claudication, Critical Limb Ischemia (CLI), and Acute Limb Ischemia are further clinical manifestations of PVD (ALI) [4]. The risk factors for PVD include age, tobacco use, diabetes mellitus, asthma, hyperlipidaemia, chronic kidney disease, obesity, and race [5].…”